Bellon Christine bought BEAM
January 31, 2024 · Form 4 insider transaction
Bellon Christine bought 55,000 shares of Beam Therapeutics Inc. at $24.40 per share, a transaction worth $1.34M. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
55,000
Price
$24.40
Total value
$1.34M
InsiderBellon Christine
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 31, 2024
Filing dateFebruary 2, 2024
Shares owned after55,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This stock option vests in equal monthly installments each month following the date of grant for the subsequent 48 months, subject to the Reporting Person's continued service with Beam Therapeutics Inc. through each vesting date